Evidence map›Paper›PMID 35787512›Full record

ArticleJournal of medical Internet research2022

StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials.

Stefan Konigorski, Sarah Wernicke, Tamara Slosarek, Alexander M Zenner, Nils Strelow, Darius F Ruether, Florian Henschel, Manisha Manaswini, Fabian Pottbäcker, Jonathan A Edelman and 6 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. N -of-1 Trials in Nephrology : Moving beyond Case Series.Journal of the American Society of Nephrology : JASN · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. THE VALUE OF N-OF-1 DATA IN ZOOLOGICAL MEDICINE: A METHODOLOGICAL REVIEW.Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians · 2023
    Review
  15. N-of-1 trials: The epitome of personalized medicine?Journal of clinical and translational science · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Stefan KonigorskiDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0002-9966-6819
Sarah WernickeDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0001-8127-1969
Tamara SlosarekDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0003-1514-1706
Alexander M ZennerDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0002-6745-1610
Nils StrelowDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0002-7629-1284
Darius F RuetherDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0003-3783-380X
Florian HenschelDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0003-2653-0539
Manisha ManaswiniDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0003-4403-7692
Fabian PottbäckerDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0001-8446-1776
Jonathan A EdelmanDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0002-7611-0615
Babajide OwoyeleDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0002-3688-5248
Matteo DanielettoHasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID 0000-0002-5178-9182
Eddye GoldenHasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID 0000-0002-9818-5693
Micol ZweigHasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID 0000-0001-8190-7197
Girish N NadkarniHasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID 0000-0001-6319-4314
Erwin BöttingerDigital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam, Potsdam, Germany.ORCID 0000-0001-6868-6676

Funding

COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
NIH HHS S10 OD026880NIH HHS S10 OD030463
6 · The paper itself

Abstract

N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.

Indexed as

Mobile ApplicationsHumansResearch Designappdigital healthdigital interventionsmobile applicationN-of-1 trialSCEDsingle-case experimental designweb application

Identifiers

PMID35787512
PMCPMC9297132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.